Articles

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells

Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, Oxford University, London, UK
Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, Oxford University, London, UK
Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, Oxford University, London, UK
Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, Oxford University, London, UK
Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, Oxford University, London, UK
Immunity and Cancer Laboratory, The Francis Crick Institute, Lincoln’s Inn Fields Laboratory, Lincoln’s Inn Fields, London, UK
Computational Biology Laboratory, The Francis Crick Institute, Lincoln’s Inn Fields Laboratory, Lincoln’s Inn Fields, London, UK
Leeds Teaching Hospitals NHS Trust, HMDS, Leeds Cancer Centre, Kings College London, UK
Centre of Excellence for Mass Spectrometry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK
Immunity and Cancer Laboratory, The Francis Crick Institute, Lincoln’s Inn Fields Laboratory, Lincoln’s Inn Fields, London, UK;Peter Gorer Department of Immunobiology, Kings College London, UK
Centre of Excellence for Mass Spectrometry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK
Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, Oxford University, London, UK
Vol. 101 No. 7 (2016): July, 2016 https://doi.org/10.3324/haematol.2016.142141